EXOZ
eXoZymes, Inc.
NASDAQ · Healthcare · Biotechnology · US
$6.85
+0.74%Leverage
- Debt / equity
- 0.30x
- Net debt / equity
- -1.25x
- Debt / assets
- 0.14x
- Debt / EBITDA
- -0.10x
- Net debt / EBITDA
- 0.43x
Liquidity & coverage
- Current ratio
- 3.81x
- Quick ratio
- 3.81x
- Cash ratio
- 3.49x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $4.6M
Cash & dividend
- FCF / debt
- -6.58x
- Cash flow / debt
- -6.45x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026